| Year |
Citation |
Score |
| 2017 |
Coban H, Robertson K, Smurzynski M, Krishnan S, Wu K, Bosch RJ, Collier AC, Ellis RJ. Impact of aging on neurocognitive performance in previously antiretroviral-naïve HIV+ individuals on their first suppressive regimen. Aids (London, England). PMID 28471765 DOI: 10.1097/Qad.0000000000001523 |
0.549 |
|
| 2014 |
Mollan KR, Smurzynski M, Eron JJ, Daar ES, Campbell TB, Sax PE, Gulick RM, Na L, O'Keefe L, Robertson KR, Tierney C. Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data. Annals of Internal Medicine. 161: 1-10. PMID 24979445 DOI: 10.7326/M14-0293 |
0.401 |
|
| 2014 |
Kang M, Hollabaugh K, Pham V, Koletar SL, Wu K, Smurzynski M, Aberg JA. Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 172-80. PMID 24694927 DOI: 10.1097/Qai.0000000000000149 |
0.448 |
|
| 2014 |
Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC. Plasma apolipoprotein L1 levels do not correlate with CKD. Journal of the American Society of Nephrology : Jasn. 25: 634-44. PMID 24231663 DOI: 10.1681/Asn.2013070700 |
0.384 |
|
| 2013 |
Smurzynski M, Wu K, Schouten JT, Lok JJ, Bosch RJ, Taiwo B, Johnson VA, Collier AC. Factors associated with remaining on initial randomized efavirenz-containing regimens. Aids (London, England). 27: 1887-97. PMID 23925417 DOI: 10.1097/Qad.0B013E328361645F |
0.374 |
|
| 2013 |
Overton ET, Kitch D, Benson CA, Hunt PW, Stein JH, Smurzynski M, Ribaudo HJ, Tebas P. Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1471-9. PMID 23386631 DOI: 10.1093/Cid/Cit053 |
0.356 |
|
| 2011 |
Krishnan S, Wu K, Smurzynski M, Bosch RJ, Benson CA, Collier AC, Klebert MK, Feinberg J, Koletar SL. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis. Hiv Clinical Trials. 12: 190-200. PMID 22044855 DOI: 10.1310/Hct1204-190 |
0.473 |
|
| 2011 |
Ribaudo HJ, Benson CA, Zheng Y, Koletar SL, Collier AC, Lok JJ, Smurzynski M, Bosch RJ, Bastow B, Schouten JT. No risk of myocardial infarction associated with initial antiretroviral treatment containing abacavir: short and long-term results from ACTG A5001/ALLRT. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 929-40. PMID 21427402 DOI: 10.1093/Cid/Ciq244 |
0.464 |
|
| 2011 |
Smurzynski M, Wu K, Letendre S, Robertson K, Bosch RJ, Clifford DB, Evans S, Collier AC, Taylor M, Ellis R. Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort. Aids (London, England). 25: 357-65. PMID 21124201 DOI: 10.1097/Qad.0B013E32834171F8 |
0.454 |
|
| 2011 |
Linas BP, Wang B, Smurzynski M, Losina E, Bosch RJ, Schackman BR, Rong J, Sax PE, Walensky RP, Schouten J, Freedberg KA. The impact of HIV/HCV co-infection on health care utilization and disability: results of the ACTG Longitudinal Linked Randomized Trials (ALLRT) Cohort. Journal of Viral Hepatitis. 18: 506-12. PMID 20546501 DOI: 10.1111/J.1365-2893.2010.01325.X |
0.536 |
|
| 2010 |
Smurzynski M, Wu K, Benson CA, Bosch RJ, Collier AC, Koletar SL. Relationship between CD4+ T-cell counts/HIV-1 RNA plasma viral load and AIDS-defining events among persons followed in the ACTG longitudinal linked randomized trials study. Journal of Acquired Immune Deficiency Syndromes (1999). 55: 117-27. PMID 20622677 DOI: 10.1097/Qai.0B013E3181E8C129 |
0.349 |
|
| 2009 |
Brown TT, Smurzynski M, Wu K, Bosch RJ, McComsey GA. Statin therapy and changes in hip circumference among HIV-infected participants in the ALLRT Cohort. Antiviral Therapy. 14: 853-8. PMID 19812448 DOI: 10.3851/Imp1300 |
0.475 |
|
| 2009 |
Clifford DB, Smurzynski M, Park LS, Yeh TM, Zhao Y, Blair L, Arens M, Evans SR. Effects of active HCV replication on neurologic status in HIV RNA virally suppressed patients. Neurology. 73: 309-14. PMID 19636051 DOI: 10.1212/Wnl.0B013E3181Af7A10 |
0.446 |
|
| 2009 |
Gupta SK, Smurzynski M, Franceschini N, Bosch RJ, Szczech LA, Kalayjian RC. The effects of HIV type-1 viral suppression and non-viral factors on quantitative proteinuria in the highly active antiretroviral therapy era. Antiviral Therapy. 14: 543-9. PMID 19578239 |
0.444 |
|
| 2009 |
Patterson KB, Cohn SE, Uyanik J, Hughes M, Smurzynski M, Eron JJ. Treatment responses in antiretroviral treatment-naive premenopausal and postmenopausal HIV-1-infected women: an analysis from AIDS Clinical Trials Group Studies. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 473-6. PMID 19555288 DOI: 10.1086/600398 |
0.449 |
|
| 2008 |
Smurzynski M, Collier AC, Koletar SL, Bosch RJ, Wu K, Bastow B, Benson CA. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics. Hiv Clinical Trials. 9: 269-82. PMID 18753121 DOI: 10.1310/Hct0904-269 |
0.445 |
|
| 2008 |
Kalayjian RC, Franceschini N, Gupta SK, Szczech LA, Mupere E, Bosch RJ, Smurzynski M, Albert JM. Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. Aids (London, England). 22: 481-7. PMID 18301060 DOI: 10.1097/Qad.0B013E3282F4706D |
0.489 |
|
| 2007 |
Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ. The prevalence and incidence of neurocognitive impairment in the HAART era. Aids (London, England). 21: 1915-21. PMID 17721099 DOI: 10.1097/Qad.0B013E32828E4E27 |
0.475 |
|
| 2007 |
Ford CL, Miller WC, Smurzynski M, Leone PA. Key components of a theory-guided HIV prevention outreach model: pre-outreach preparation, community assessment, and a network of key informants. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 19: 173-86. PMID 17411419 DOI: 10.1521/Aeap.2007.19.2.173 |
0.509 |
|
| 2004 |
Hightow LB, Miller WC, Leone PA, Wohl DA, Smurzynski M, Kaplan AH. Predictors of repeat testing and HIV seroconversion in a sexually transmitted disease clinic population. Sexually Transmitted Diseases. 31: 455-9. PMID 15273576 DOI: 10.1097/01.Olq.0000135984.27593.5F |
0.565 |
|
| 2004 |
Tilson EC, Sanchez V, Ford CL, Smurzynski M, Leone PA, Fox KK, Irwin K, Miller WC. Barriers to asymptomatic screening and other STD services for adolescents and young adults: focus group discussions. Bmc Public Health. 4: 21. PMID 15189565 DOI: 10.1186/1471-2458-4-21 |
0.481 |
|
| 2003 |
Hightow LB, Miller WC, Leone PA, Wohl D, Smurzynski M, Kaplan AH. Failure to return for HIV posttest counseling in an STD clinic population. Aids Education and Prevention : Official Publication of the International Society For Aids Education. 15: 282-90. PMID 12866839 DOI: 10.1521/Aeap.15.4.282.23826 |
0.607 |
|
| 2002 |
Pilcher CD, McPherson JT, Leone PA, Smurzynski M, Owen-O'Dowd J, Peace-Brewer AL, Harris J, Hicks CB, Eron JJ, Fiscus SA. Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population. Jama. 288: 216-21. PMID 12095386 DOI: 10.1001/Jama.288.2.216 |
0.539 |
|
| Show low-probability matches. |